Imaging and Alzheimer disease: current issues
Frackowiak, R.S.
Alzheimer Disease and Associated Disorders 9(1): 5
1995
ISSN/ISBN: 0893-0341 PMID: 7605622 Document Number: 441117
Document emailed within 1 workday
Related Documents
Tariot, P.N. 2006: Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies Journal of Clinical Psychiatry 67(Suppl 3): 15-22; Quiz 23Fărcăşel, L. 1988: Current data on the anatomy and physiopathology of Alzheimer's disease (Alzheimer-type senile dementia--ATSD) Revista Medico-Chirurgicala A Societatii de Medici Si Naturalisti Din Iasi 92(2): 289-292
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Andrieu, S.; Rascol, O.; Lang, T.; Grandjean, H.; Vellas, B. 2006: Disease modifying trials in Alzheimer disease: methodological and statistical issues Journal of Nutrition Health and Aging 10(2): 116-117
Soetaert, G.; Steinling, M.; Leys, D.; Gaudet, Y.; Fauquette, A.; Petit, H. 1989: Alzheimer's disease: imaging with NMR Acta Neurologica Belgica 89(3-4): 246-248
Cassel, C.K. 1998: Genetic testing and Alzheimer disease: ethical issues for providers and families Alzheimer Disease and Associated Disorders 12(Suppl 3): S16-S20
Frey, K.A.; Minoshima, S.; Kuhl, D.E. 1998: Neurochemical imaging of Alzheimer's disease and other degenerative dementias Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 42(3): 166-178
Trombella, S.; Assal, F.éd.ér.; Zekry, D.; Gold, G.; Giannakopoulos, P.; Garibotto, V.; Démonet, J.-F.ço.; Frisoni, G.B. 2016: Brain imaging of Alzheimer' disease: state of the art and perspectives for clinicians Revue Medicale Suisse 12(515): 795-798
Scheinin, N.M.; Scheinin, M.; Rinne, J.O. 2011: Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's disease Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 55(3): 265-279
van Gool, W.A.; Eikelenboom, P. 1994: Current aspects of Alzheimer's disease Nederlands Tijdschrift Voor Geneeskunde 138(3): 116-118
Musiek, E.S.; Schindler, S.E. 2013: Alzheimer disease: current concepts and future directions Missouri Medicine 110(5): 395-400
Gualdi, G.F.; Colaiacomo, M.C.; Bertini, L.; Melone, A.; Rojas, M.; Di Biasi, C. 2004: Neuroimaging of Alzheimer disease: current role and future potential La Clinica Terapeutica 155(10): 429-438
Vellas, B.; Andrieu, S.; Ousset, P.J.; Ouzid, M.; Mathiex-Fortunet, H. 2006: The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint Neurology 67(9 Suppl 3): S6-S11
Farlow, M.R. 2001: Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine Clinical Therapeutics 23(Suppl): A13-A24
Xing, M.; Ai, Y-mei.; He, R-lian.; Gao, J-wei.; Song, P-ping.; Wang, X-cheng.; Gao, C-hong.; Zhang, H-min.; Yu, H-mei. 2012: Current status and influencing factors regarding quality of life among patients with Alzheimer's disease Zhonghua Liu Xing Bing Xue Za Zhi 33(6): 606-609
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Eleti, S. 2016: Drugs in Alzheimer's disease Dementia: An overview of current pharmacological management and future directions Psychiatria Danubina 28(Suppl-1): 136-140